This article reviews a range of methods for identifying high-risk patients with unstable coronary artery disease, including clinical evaluation, the resting 12-lead electrocardiogram, continuous vectorcardiography, and a combined risk evaluation using continuous vectorcardiography and measurement of troponin-T. Clinical evaluation is not very accurate for identifying high-risk patients and modern techniques have not been fully validated in clinical trials. The combination of continuous vectorcardiography and biochemical monitoring is a very powerful method of identifying both very high- and very low-risk patients and may be increasingly used in the future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0002-9149(97)00488-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!